Gabelli Funds LLC Ligand Pharmaceuticals Inc Transaction History

Gabelli Funds LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $2.74 Million - $5.94 Million	-27,500 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$80.55 - $106.05 $402,750 - $530,250	-5,000 Reduced 15.38%	27,500 $2.74 Million
Q3 2020 Nov 06, 2020	BUY	$89.56 - $126.72 $985,160 - $1.39 Million	11,000 Added 51.16%	32,500 $3.1 Million
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $1.8 Million - $3.25 Million	-26,302 Reduced 55.02%	21,500 $2.41 Million
Q1 2020 May 14, 2020	SELL	$63.37 - $107.88 $633,700 - $1.08 Million	-10,000 Reduced 17.3%	47,802 $3.48 Million
Q3 2019 Nov 01, 2019	BUY	$86.25 - $120.16 $43,125 - $60,080	500 Added 0.87%	57,802 $5.75 Million
Q1 2019 May 02, 2019	BUY	$105.93 - $142.47 $1.78 Million - $2.39 Million	16,802 Added 41.49%	57,302 $7.2 Million
Q4 2018 Jan 30, 2019	BUY	$128.36 - $272.13 $3.02 Million - $6.4 Million	23,500 Added 138.24%	40,500 $5.5 Million
Q2 2018 Aug 10, 2018	SELL	$150.77 - $207.98 $1.59 Million - $2.2 Million	-10,575 Reduced 38.35%	17,000 $3.52 Million
Q1 2018 May 09, 2018	SELL	$138.63 - $182.62 $623,835 - $821,790	-4,500 Reduced 14.03%	27,575 $4.55 Million
Q4 2017 Feb 02, 2018	SELL	$128.36 - $147.04 $192,540 - $220,560	-1,500 Reduced 4.47%	32,075 $4.39 Million
Q3 2017 Nov 01, 2017	BUY	$120.91 - $137.94 $4.06 Million - $4.63 Million	33,575	33,575 $4.57 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.